Prostate Cancer Reports


Volume 1 Supplement 4
 April 2013
Home > Prostate Cancer Reports > Volume 1 - Year 2013 > Supplement 4, April 2013

CONTENTS



Clinical & Lab investigations
Localized PCa
Locally advanced PCa
Advanced PCa
High-risk PCa



CLINICAL & LAB INVESTIGATIONS


Mortality

Boorjian SA, Thompson RH, Tollefson MK, Rangel LJ, Bergstralh EJ, Blute ML, Karnes RJ.
Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence.
Eur Urol. 2011 Jun;59(6):893-9. doi: 10.1016/j.eururo.2011.02.026. Epub 2011 Feb 22.
Abstract | Full text | Related citations


Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, Walsh PC, Partin AW.
Death in patients with recurrent prostate cancer after radical prostatectomy: prostate-specific antigen doubling time subgroups and their associated contributions to all-cause mortality.
J Clin Oncol. 2007 May 1;25(13):1765-71.
Abstract | Full text | Related citations


Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, Walsh PC, Partin AW.
Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy.
JAMA. 2005 Jul 27;294(4):433-9.
Abstract | Full text | Related citations



Guillonneau BD, Fizazi K.
Natural history of patients presenting biochemical recurrence after radical prostatectomy: some good news?
Eur Urol. 2011 Jun;59(6):900-1. doi: 10.1016/j.eururo.2011.02.043. Epub 2011 Mar 17.
Abstract | Full text | Related citations


Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC.
Natural history of progression after PSA elevation following radical prostatectomy.
JAMA. 1999 May 5;281(17):1591-7.
Abstract | Full text | Related citations


Nomograms

Ross RW, Kantoff PW.
Predicting outcomes in prostate cancer: how many more nomograms do we need?
J Clin Oncol. 2007 Aug 20;25(24):3563-4.
Abstract | Full text | Related citations


Overviews

Roth BJ, Krilov L, Adams S, Aghajanian CA, Bach P, Braiteh F, Brose MS, Ellis LM, Erba H, George DJ, Gilbert MR, Jacobson JO, Larsen EC, Lichtman SM, Partridge AH, Patel JD, Quinn DI, Robison LL, von Roenn JH, Samlowski W, Schwartz GK, Vogelzang NJ.
Clinical cancer advances 2012: annual report on progress against cancer from the american society of clinical oncology.
J Clin Oncol. 2013 Jan 1;31(1):131-61. doi: 10.1200/JCO.2012.47.1938. Epub 2012 Dec 3
Abstract | Full text | Erratum | Related citations


Vogelzang NJ, Benowitz SI, Adams S, Aghajanian C, Chang SM, Dreyer ZE, Janne PA, Ko AH, Masters GA, Odenike O, Patel JD, Roth BJ, Samlowski WE, Seidman AD, Tap WD, Temel JS, Von Roenn JH, Kris MG.
Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
J Clin Oncol. 2012 Jan 1;30(1):88-109. doi: 10.1200/JCO.2011.40.1919. Epub 2011 Dec 5.
Abstract | Full text | Related citations

LOCALIZED PROSTATE CANCER


Nomograms

Klein EA, Stephenson AJ, Raghavan D, Dreicer R.
Systems pathology and predicting outcome after radical prostatectomy.
J Clin Oncol. 2008 Aug 20;26(24):3916-7. doi: 10.1200/JCO.2008.17.1991.
Abstract | Full text | Related citations


Shariat SF, Walz J, Roehrborn CG, Zlotta AR, Perrotte P, Suardi N, Saad F, Karakiewicz PI.
External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy.
J Clin Oncol. 2008 Mar 20;26(9):1526-31. doi: 10.1200/JCO.2007.12.4669.
Abstract | Full text | Related citations


Recurrence

Parker C, Sydes M.
Adjuvant radiotherapy after surgery for prostate cancer.
JAMA. 2008 Nov 12;300(18):2119; author reply 2119. doi: 10.1001/jama.2008.562.
Abstract | Full text | Related citations



Roberts SG, Blute ML, Bergstralh EJ, Slezak JM, Zincke H.
PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.
Mayo Clin Proc. 2001 Jun;76(6):576-81.
Abstract | Related citations


Rogers CG, Khan MA, Craig Miller M, Veltri RW, Partin AW.
Natural history of disease progression in patients who fail to achieve an undetectable prostate-specific antigen level after undergoing radical prostatectomy.
Cancer. 2004 Dec 1;101(11):2549-56.
Abstract | Full text | Related citations



Trock BJ, Han M, Freedland SJ, Humphreys EB, DeWeese TL, Partin AW, Walsh PC.
Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy.
JAMA. 2008 Jun 18;299(23):2760-9. doi: 10.1001/jama.299.23.2760.
Abstract | Full text | Related citations


Treatment

Oliai C, Lanciano R, Sprandio B, Yang J, Lamond J, Arrigo S, Good M, Mooreville M, Garber B, Brady LW.
Stereotactic body radiation therapy for the primary treatment of localized prostate cancer.
J Radiat Oncol. 2013 Mar;2(1):63-70. Epub 2012 Sep 12.
Abstract | Full text | Related citations

LOCALLY ADVANCED PROSTATE CANCER


Recurrence

Nabhan M, Kim SP, Shah ND, Bagniewski SM, Shi Q, Karnes RJ, Weight CJ, Davis BJ, Kohli M, Tilburt JC.
The relationship of the intensity of posttreatment prostate-specific antigen surveillance and prostate cancer outcomes: results from a population-based cohort.
Mayo Clin Proc. 2012 Jun;87(6):540-7. doi: 10.1016/j.mayocp.2012.01.017.
Abstract | Full text | Related citations

ADVANCED PROSTATE CANCER


Recurrence

Swanson GP, Hussey MA, Tangen CM, Chin J, Messing E, Canby-Hagino E, Forman JD, Thompson IM, Crawford ED; SWOG 8794.
Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794.
J Clin Oncol. 2007 Jun 1;25(16):2225-9.
Abstract | Full text | Related citations


Treatment

Moinpour CM, Hayden KA, Unger JM, Thompson IM Jr, Redman MW, Canby-Hagino ED, Higgins BA, Sullivan JW, Lemmon D, Breslin S, Crawford ED, Southwest Oncology Group.
Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy.
J Clin Oncol. 2008 Jan 1;26(1):112-20. doi: 10.1200/JCO.2006.10.4505.
Abstract | Full text | Related citations

HIGH-RISK PROSTATE CANCER


Recurrence

Anscher MS.
Salvage radiotherapy for recurrent prostate cancer: the earlier the better.
JAMA. 2004 Mar 17;291(11):1380-2.
Abstract | Full text | Related citations


Stephenson AJ, Shariat SF, Zelefsky MJ, Kattan MW, Butler EB, Teh BS, Klein EA, Kupelian PA, Roehrborn CG, Pistenmaa DA, Pacholke HD, Liauw SL, Katz MS, Leibel SA, Scardino PT, Slawin KM.
Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.
JAMA. 2004 Mar 17;291(11):1325-32.
Abstract | Full text | Related citations